Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

Similar articles for PubMed (Select 12824458)

1.

The prevention of prostate cancer--the dilemma continues.

Scardino PT.

N Engl J Med. 2003 Jul 17;349(3):297-9. Epub 2003 Jun 24. No abstract available.

PMID:
12824458
2.

Re: Long-term survival of participants in the Prostate Cancer Prevention Trial.

Thompson IM Jr, Tangen CM, Goodman PJ.

Asian J Androl. 2014 May-Jun;16(3):414. No abstract available.

3.

Long-term survival of participants in the prostate cancer prevention trial.

Silberstein JL, Sartor O.

Asian J Androl. 2014 May-Jun;16(3):413-4. doi: 10.4103/1008-682X.122868. No abstract available.

4.

Are 5-ARIs suitable for prevention of prostate cancer?

Rees J.

Practitioner. 2013 Oct;257(1765):5. No abstract available.

PMID:
24367875
5.

Survival in the prostate cancer prevention trial.

Revannasiddaiah S, Susheela SP.

N Engl J Med. 2013 Nov 14;369(20):1967. doi: 10.1056/NEJMc1311498#SA2. No abstract available.

PMID:
24224634
6.

Survival in the prostate cancer prevention trial.

Walsh PC.

N Engl J Med. 2013 Nov 14;369(20):1967. doi: 10.1056/NEJMc1311498#SA1. No abstract available.

PMID:
24224633
7.

Survival in the prostate cancer prevention trial.

Tangen CM, Goodman PJ, Thompson IM Jr.

N Engl J Med. 2013 Nov 14;369(20):1968. doi: 10.1056/NEJMc1311498. No abstract available.

8.

Urological cancer: reduction in the risk of prostate cancer with finasteride.

Marchesi V.

Nat Rev Clin Oncol. 2013 Nov;10(11):608. doi: 10.1038/nrclinonc.2013.163. Epub 2013 Sep 3. No abstract available.

PMID:
23999217
9.

Finasteride for prostate cancer prevention has no effect on survival, study finds.

McCarthy M.

BMJ. 2013 Aug 20;347:f5203. doi: 10.1136/bmj.f5203. No abstract available.

PMID:
23963667
10.

A role for finasteride in the prevention of prostate cancer?

LeFevre M.

N Engl J Med. 2013 Aug 15;369(7):670-1. doi: 10.1056/NEJMe1307059. No abstract available.

PMID:
23944306
11.

The risks and benefits of 5α-reductase inhibitors for prostate-cancer prevention.

Theoret MR, Ning YM, Zhang JJ, Justice R, Keegan P, Pazdur R.

N Engl J Med. 2011 Jul 14;365(2):97-9. doi: 10.1056/NEJMp1106783. Epub 2011 Jun 15. No abstract available.

12.

Finasteride: male breast cancer.

[No authors listed]

Prescrire Int. 2010 Dec;19(111):283. No abstract available.

PMID:
21355383
13.

Prostate cancer prevention with 5 alpha-reductase inhibitors.

Parekh DJ.

Recent Results Cancer Res. 2011;188:109-14. doi: 10.1007/978-3-642-10858-7_9. Review. No abstract available.

PMID:
21253793
14.

Few physicians prescribe 5-alpha reductase inhibitors for prostate cancer prevention.

Barton MK.

CA Cancer J Clin. 2011 Jan-Feb;61(1):1-2. doi: 10.3322/caac.20100. Epub 2011 Jan 3. No abstract available.

15.

Dutasteride and prostate cancer.

Garattini S, Bertele' V.

N Engl J Med. 2010 Aug 19;363(8):794; author reply 794-6. No abstract available.

PMID:
20842790
16.

Dutasteride and prostate cancer.

Kiemeney LA, Bosland MC.

N Engl J Med. 2010 Aug 19;363(8):793; author reply 794-5. doi: 10.1056/NEJMc1005498. No abstract available.

17.

Can chemoprevention reduce the risk of prostate cancer?

Diamandis EP.

Clin Chem. 2010 Aug;56(8):1214-5. doi: 10.1373/clinchem.2010.147918. Epub 2010 Jun 21. No abstract available.

18.

Prostate cancer chemoprevention: what is the role of oncology nurses?

Leahy Y.

Can Oncol Nurs J. 2010 Winter;20(1):52-5. English, French. No abstract available.

PMID:
20369646
19.

Chemoprevention of prostate cancer.

Walsh PC.

N Engl J Med. 2010 Apr 1;362(13):1237-8. doi: 10.1056/NEJMe1001045. No abstract available.

PMID:
20357287
20.

Chemoprevention of prostate cancer.

Stephenson AJ, Abouassaly R, Klein EA.

Urol Clin North Am. 2010 Feb;37(1):11-21, Table of Contents. doi: 10.1016/j.ucl.2009.11.003. Review.

PMID:
20152515
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk